Dhruv Kumar Nishad
Overview
Explore the profile of Dhruv Kumar Nishad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khanna K, Sharma N, Karwasra R, Kumar A, Nishad D, Janakiraman A, et al.
J Drug Target
. 2024 Sep;
33(1):99-110.
PMID: 39229894
Background: Intranasal drug delivery shows potential for brain access via olfactory and trigeminal routes. Purpose: This work aimed to ensure brain availability of nalbuphine via the nasal route. Method: Chitosan...
2.
Synthetic and Natural Radioprotective Agents: Recent Status and their Underlying Mechanism of Action
Mishra J, Poonia N, Lather V, Nishad D, Pandita D
Curr Pharm Biotechnol
. 2024 May;
PMID: 38818911
Various substances possessing radiation scavenging properties, known as radioprotectors, play a crucial role in shielding organisms from the harmful effects of ionizing radiation (IR) by preventing cellular damage caused by...
3.
Sharma N, Sharma A, Rai Y, Karwasra R, Khanna K, Nishad D, et al.
Exp Clin Transplant
. 2022 Jul;
20(6):569-579.
PMID: 35791830
Objectives: The objective of organ preservation is sustained viability of detached/removed/isolated organs and subsequent successful posttransplant outcomes. Nicorandil (an ATP-sensitive potassium channel opener) is an efficacious agent to preserve lungs...
4.
Grover P, Bhatnagar A, Kumari N, Narayan Bhatt A, Nishad D, Purkayastha J
Saudi J Biol Sci
. 2021 Mar;
28(3):1853-1859.
PMID: 33732072
A pigment-protein highly dominant in Spirulina is known as C-Phycocyanin. Earlier, studies has shown that C-phycocyanin is having many biological activities like antioxidant and anti-inflammatory activities, antiplatelet, hepatoprotective, and cholesterol-lowering...
5.
Khanna K, Sharma N, Rawat S, Khan N, Karwasra R, Hasan N, et al.
Chem Phys Lipids
. 2021 Feb;
236:105060.
PMID: 33582127
Pain is a noxious stimulus caused due to tissue damage and varies from mild to severe. Nalbuphine (NLB) is an approved, inexpensive, non-controlled, opioid agonist/antagonist analgesic used worldwide in various...
6.
Kumar M, Nishad D, Kumar A, Bhatnagar A, Karwasra R, Khanna K, et al.
J Microencapsul
. 2020 Jul;
37(7):492-501.
PMID: 32715833
Aim: For the treatment of cerebral ischaemia, vitamin-D loaded nanoemulsions were developed. Method: Tween 20 and polyethylene glycol were chosen as surfactant/co-surfactant, while oleic acid as the oil phase. The...
7.
Khanna K, Karwasra R, Choudhary S, Sharma D, Sharma N, Nagpal P, et al.
Injury
. 2020 Jun;
51(9):1970-1978.
PMID: 32591214
Background: Nalbuphine (NLB) is a kappa-agonist and mu-partial antagonist, widely used for opioid withdrawal de-addiction, opioid-induced pruritis and as emergent analgesia. Objective: The present study aimed to assess the safety...
8.
Khanna K, Sharma D, Khar R, Karwasra R, Sharma N, Nishad D, et al.
Int J Low Extrem Wounds
. 2019 Sep;
19(2):148-157.
PMID: 31496323
Wounds and related injuries remain a major cause of death and disability. Healing of wound is a complex, highly regulated process that includes cellular, molecular, biochemical, and physiological events that...
9.
Sultana S, Talegaonkar S, Nishad D, Mittal G, Ahmad F, Bhatnagar A
Eur J Pharm Biopharm
. 2017 Jun;
126:221-232.
PMID: 28629719
The purpose of this research work was to prepare nanosized formulation of alpha ketoglutarate as dry powder inhaler for cyanide poisoning. Nanosizing can be approached by solid phase and liquid...
10.
Nishad D, Bhalla S, Khanna K, Sharma B, Rawat H, Mittal G, et al.
Cutan Ocul Toxicol
. 2017 Apr;
37(1):1-8.
PMID: 28372461
Radioactive skin contamination is one of the most likely risks which occurs after accidental or occupational radiological accidents apart from internal contamination. In such cases where the radioactive contamination has...